|
FY2023
12 months to Aug 31, 2023
|
FY2022
12 months to Aug 31, 2022
|
FY2021
12 months to Aug 31, 2021
|
|
|---|---|---|---|
| Revenues [note 20] | |||
| Cost of sales [note 7] | |||
| Cost of sales - EMotion | |||
| Gross profit | |||
| Expenses | |||
| Research and development [note 17] | |||
| Office salaries and benefits [note 17] | |||
| Rent | |||
| Selling and marketing expenses | |||
| Professional fees | |||
| Travel and entertainment | |||
| Advertising and promotion | |||
| Office and general | |||
| Interest and bank charges | |||
| Interest on long-term debt and leases | |||
| Foreign exchange loss | |||
| Loss on debentures [note 8] | |||
| Share-based compensation [note 19] | |||
| Impairment loss on debentures [note 8] | |||
| Depreciation | |||
| Net finance income (expense) [note 22] | |||
| Other income | |||
| Other expenses | |||
| Operating expense | |||
| Loss before tax | |||
| Income taxes [note 23] | |||
| Current tax expense (recovery) | |||
| Deferred tax expense (recovery) | |||
| Total income tax expense (recovery) | |||
| Net loss for the period | |||
| Items of comprehensive income that will be subsequently reclassified to earnings: | |||
| Foreign currency translation differences for foreign operations, net of tax | |||
| Other comprehensive income, net of tax | |||
| Total comprehensive loss for the year, net of tax | |||
| Weighted average shares outstanding, Basic | |||
| Basic and diluted earnings (loss) per share | |||
| Weighted average shares outstanding, Diluted | |||
| Basic loss per share | |||
| Diluted loss per share |
Loading...